Carbamic acid,N,N'-[2,5-bis(1-aziridinyl)-3,6-dioxo-1,4-cyclohexadiene-1,4-diyl]bis-,C,C'-diethyl ester cas no:57998-68-2

NameCarbamic acid,N,N'-[2,5-bis(1-aziridinyl)-3,6-dioxo-1,4-cyclohexadiene-1,4-diyl]bis-,C,C'-diethyl ester
CAS57998-68-2
Synonyms1,4-Cyclohexadiene-1,4-dicarbamicacid, 2,5-bis(1-aziridinyl)-3,6-dioxo-, diethyl ester (6CI,7CI); Carbamic acid,[2,5-bis(1-aziridinyl)-3,6-dioxo-1,4-cyclohexadiene-1,4-diyl]bis-, diethylester (9CI); 2,5-Diaziridinyl-3,6-bis(carboethoxyamino)-1,4-benzoquinone;3,6-Diaziridinyl-2,5-bis(carboethoxyamino)-1,4-benzoquinone; AZQ;Aziridinylbenzoquinone; CI 904; Diaziquone; NSC 182986
Molecular FormulaC16H20 N4 O6
Molecular Weight 364.40

refractive index1.62

Hazard Xn
Risk 40
Safety

Poison by intravenous and intraperitoneal routes. Human mutation data reported. When heated to decomposition it emits toxic fumes of NO_x. See also CARBAMATES and ESTERS.

1.		mmo-sat 10 µg/plate		TCMUD8    Teratogenesis, Carcinogenesis, and Mutagenesis. 5 (1985),319.
2.		dnd-omi 1 µmol/L		PAACA3    Proceedings of the American Association for Cancer Research. 24 (1983),322.
3.		dnd-hmn:emb 50 µmol/L		PAACA3    Proceedings of the American Association for Cancer Research. 24 (1983),246.
4.		dnd-hmn:oth 75 µmol/L		CNREA8    Cancer Research. 44 (1984),4447.
5.		dnd-mus:leu 57 µmol/L		PAACA3    Proceedings of the American Association for Cancer Research. 24 (1983),246.
6.		dnd-ham:ovr 50 µmol/L		CNREA8    Cancer Research. 44 (1984),5634.
7.		dns-ham:ovr 300 nmol/L		PAACA3    Proceedings of the American Association for Cancer Research. 24 (1983),322.
8.		ipr-mus LD50:11,290 µg/kg		NCISP*    National Cancer Institute Screening Program Data Summary, Developmental Therapeutics Program, Bethesda, MD 20205 JAN86 .
9.		ivn-mus LD50:10,300 µg/kg		NTIS**    National Technical Information Service. (Springfield, VA 22161) (Formerly U.S. Clearinghouse for Scientific and Technical Information) PB80-177934 .